Assessing the impact of a self-guided digital intervention for fear of cancer recurrence (iConquerFear) in ovarian cancer survivors: a pilot randomised waitlist-controlled trial

niversity of New South Wales0 个研究点目标入组 60 人开始时间: 2022年4月21日最近更新: 2022年4月25日

适应症

试验速览

暂无简介。

•The study will include those who:
•a)Are 18 years of age or older,
•b)were diagnosed with early (stages I-II) or locally-advanced ovarian cancer (stage III),
•c)have completed hospital-based treatment (surgery, radiotherapy or chemotherapy),
•d)are able to provide informed consent to participate in research,
•e)are proficient in English (i.e. able to read, write and speak English),
•f)have low to moderate levels of depression (PHQ-9 scores equal or more than 20) and no suicidal ideation (equal to 0 on the PHQ-9 item-9)
•g)have an email address and regular access to the internet, and
•h)have an electronic device such as a PC, laptop, tablet or smartphone.

•The study will exclude those who:
•a)Are 17 years or younger,
•b)are not able to provide informed consent to participate in research,
•c)are not English proficient (able to read, write and speak English),
•d)have not had a diagnosis of ovarian cancer,
•e)have been diagnosed with stage IV ovarian cancer,
•f)have not completed initial treatment yet,
•g)are diagnosed with an ovarian cancer recurrence during the study,
•h)have severe levels of depression (PHQ-9 equal to or less than 19) or suicidal ideation (greater than or equal to 1 on PHQ-9 item-9)
•i)do not have an email address and regular access to the internet, and
•j)do not have an electronic device such as a PC, laptop, iPad or smartphone.

发起方